Market Research Size

Tuesday, 27 April 2021

Pharmacy Automation Devices Market is Anticipated to Upgrade $9.5 Billion Revenue By 2028: Grand View Research Inc.

Pharmacy Automation Devices Market Growth & Trends

The global pharmacy automation devices market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions. This, in turn, is resulting in a rise in the number of medication errors. For instance, 237.4 million medication errors occurred in England in 2018, according to the article published in The Pharmaceutical Journal. This is driving the demand for pharmacy automation devices. Moreover, an increase in initiatives by various organizations, such as the American Society of Health-System Pharmacists, to reduce medication errors is positively impacting the market growth.

In 2020, the medication dispensing systems product segment accounted for the largest revenue share owing to the benefits offered by these products, such as minimized medication errors, better inventory management, improved medication adherence for patients with complex treatments, improved patient care, minimized drug waste with true split-fills, improved storage capacity, and reduced administrative burden among the end-users. The automated medication compounding systems segment is anticipated to witness the fastest growth during the forecast period. Reduction in compounding errors and contamination is a major factor driving the segment. Moreover, the increasing adoption of these devices for sterile compounding is fueling the segment growth.

The retail pharmacy end-use segment accounted for the largest revenue share in 2020. The rising adoption of these solutions, the presence of a large number of retail pharmacies, and growing investments in this sector are driving the segment. For instance, in May 2018, McKesson Co., a Healthcare Information Technology (HIT) company, entered into an agreement with Discount Drug Mart, which is an Ohio-based retail drug store, to build an automated central fill pharmacy. The hospital pharmacy is anticipated to witness the fastest growth during the forecast period owing to the adoption of automated technologies by hospitals. For instance, in February 2020, Geisinger, a health provider in the U.S., partnered with Omnicell, Inc. for the implementation of an automated dispensing system.

In 2020, North America dominated the market. This is attributed to the presence of a large number of industry players, such as BD, Omnicell, Baxter, AmerisourceBergen, and Cerner. The majority of the companies such as BD and Baxter generated more than 50% of sales revenue in the U.S. Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rapid adoption in automated solutions, investments in the adoption of healthcare IT infrastructure, and high healthcare spending are the key factors contributing to the growth of the market. Moreover, initiatives by public and private bodies to reduce medication errors are likely to drive the regional market.

Request a free sample copy or view report summary: Pharmacy Automation Devices Market Report

Pharmacy Automation Devices Market Report Highlights

The market is driven by various technological advancements and increasing investments in the automation sector
Based on product, the medication dispensing systems segment dominated the market in 2020 owing to the increasing adoption of these products to avoid errors while dispensing medication
By end-use, the retail pharmacy segment dominated the market in 2020 owing to high adoption rates of these devices and investments by major retail chains, such as CVS Health and Walgreens
North America dominated the market in 2020 owing to the presence of a large number of automation companies in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmacy-automation-market

Pharmacy Automation Devices Market Segmentation

Grand View Research, Inc. has segmented the global pharmacy automation devices market on the basis of product, end-use, and region:

Pharmacy Automation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

Medication Dispensing Systems
Packaging and Labeling Systems
Storage and Retrieval Systems
Automated Medication Compounding Systems
Tabletop Tablet Counters

Pharmacy Automation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospital Pharmacy
Retail Pharmacy

Pharmacy Automation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Spain
- Italy
- Russia
Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- South Korea
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

List of Key Players of Pharmacy Automation Devices Market

Amerisource Bergen Corporation
Accu Chart Plus Healthcare Systems, Inc.
Omnicell, Inc.
McKesson Corporation
Pearson Medical Technologies, LLC
Baxter
Talyst, LLC
ScriptPro, LLC
CareFusion (Becton Dickinson And Company)
Medacist Solutions Group, LLC
Kirby Lester
Cerner Corporation
iA
ARxIUM
TouchPoint Medical
Deenova S.R.L
Parata Systems, LLC
Swisslog Healthcare
Yuyama Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 26 April 2021

Hemoglobinopathies Market Valuation to Reach $15.7 Billion by the end of 2028

Hemoglobinopathies Market Growth & Trends

The global hemoglobinopathies market size is expected to reach USD 15.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.8% from 2021 to 2028. Increasing awareness regarding hemoglobinopathies and government initiatives to diagnose the diseases at an early stage are expected to propel the market growth over the forecast period. Moreover, increasing R&D investment, the presence of a promising drug pipeline, and technologically advanced diagnostics platforms are expected to boost the growth of the market.

The development of novel curative technologies, such as CRISPR/Cas9 and hematopoietic stem cell transplantation, coupled with a promising pipeline, is expected to propel market growth. Moreover, the presence of regulatory agencies, such as the FDA, which are working toward improving drug approval rate by granting accelerated approval for hemoglobinopathies drugs, is expected to drive the market. For instance, in 2019, the FDA has approved four novel drugs: Reblozyl by Bristol-Myers Squibb Company, Adakveo by Novartis AG, Zynteglo by bluebird bio, Inc., and Oxbryta by Global Blood Therapeutics, Inc. for the treatment of hemoglobinopathies.

Initiatives such as the Sickle Cell Awareness Initiative (SCAI) are working toward educating the people about the disease, which will increase the diagnosis and treatment rate. SCAI also raises funds for individuals affected with sickle cell diseases (SCDs) and provides research funding. Moreover, governments of Middle Eastern and Asian countries provide funds for R&D of hemoglobinopathies treatment. For instance, various programs undertaken by governments, such as thalassemia screening in neonates and providing medicines, are impacting the market growth positively.

The high patient population in low-income countries has encouraged market players and non-profit organizations to launch several initiatives to improve the access to the therapy. For instance, in February 2019, the Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) was launched by Global Blood Therapeutics, Inc. in order to provide research funding for novel SCD projects, with an aim to expand the access to optimal healthcare for sickle cell disease.

Biopharmaceutical companies are collaborating with nonprofit organizations to promote public awareness about hemoglobinopathies. For instance, in June 2018, the Sickle Cell Disease Association of America partnered with Emmaus Life Sciences, Inc. to provide online educational tools to sickle cell patients, friends, clinicians, caregivers, and researchers for spreading awareness about complications associated with SCD.

An increase in investment and funding for the development of novel therapies to treat hemoglobinopathies will further boost the market growth over the forecast period. The National Heart, Lung, and Blood Institute (NHLBI) has significantly invested in research & development in sickle cell disease. The NHLBI supports research work through various initiatives. Furthermore, private funding such as the Bronx Blood Research Fund (BBRF) provides a platform for research and management of thalassemia and other hemoglobinopathies.

Gene therapy has emerged as a promising treatment option for managing hemoglobin disorder as it targets the underlying genetic cause of the condition through the administration of one-time gene therapy and significantly reduces the need for blood transfusions. The current pipeline of gene therapy products includes CTX001 (CRISPR Therapeutics), BIVV003 (Sangamo Therapeutics, Inc. & Bioverativ Inc), and HGB-206 (bluebird bio, Inc).

Request a free sample copy or view report summary: Hemoglobinopathies Market Report

Hemoglobinopathies Market Report Highlights

Based on type, sickle cell disease accounted for the largest share of 56.6% in 2020 and is anticipated to maintain its lead over the forecast period
The newborn patient population with sickle cell anemia is anticipated to reach 400,000 by 2050. Half of the global sickle cell anemia burden is present in India, Nigeria, and the Democratic Republic of the Congo
By therapy, in the thalassemia segment, the blood transfusion segment held the largest market share in 2020 and is estimated to dominate the market throughout the forecast period
Asia Pacific is expected to witness the fastest growth over the forecast period owing to a large potential patient base and high unmet medical needs in the region
North America held the largest market share in 2020 due to government initiatives focusing on the development of new therapies and better reimbursement scenario

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hemoglobinopathies-market

Hemoglobinopathies Market Segmentation

Grand View Research has segmented the global hemoglobinopathies market on the basis of type, diagnosis, therapy, and region:

Hemoglobinopathies Type Outlook (Revenue, USD Million, 2017 - 2028)

Thalassemia
Sickle Cell Disease
Other Hemoglobin (Hb) Variants

Hemoglobinopathies Diagnosis Outlook (Revenue, USD Million, 2017 - 2028)

Thalassemia
- Blood Test
- Genetic Test
- Prenatal Genetic Test
- Pre-implantation Genetic Diagnosis
- Electrophoresis
- Others
Sickle Cell Disease
- Blood Test
- Genetic Test
- Prenatal Genetic Test
- Electrophoresis
- Others
Other Hemoglobin (Hb) Variants
- Blood Test
- Genetic Test
- Prenatal Genetic Test
- Electrophoresis
- Others

Hemoglobinopathies Therapy Outlook (Revenue, USD Million, 2017 - 2028)

Thalassemia
- Blood Transfusion
- Iron Chelation Therapy
- Bone Marrow Transplant
- Others
Sickle Cell Disease
- Blood Transfusion
- Hydroxyurea
- Bone Marrow Transplant
- Others
Other Hemoglobin (Hb) Variants
- Blood Transfusion
- Hydroxyurea
- Iron Chelation Therapy
- Bone Marrow Transplant
- Others

Hemoglobinopathies Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
- Russia
Asia Pacific
- India
- China
- Japan
- Singapore
- Australia
- South Korea
Latin America
- Argentina
- Brazil
- Mexico
Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa

List of Key Players of Hemoglobinopathies Market

Sangamo Therapeutics, Inc.
Global Blood Therapeutics, Inc.
bluebird bio, Inc.
Emmaus Life Sciences Inc.
Pfizer, Inc.
Novartis AG
Prolong Pharmaceuticals, LLC
Bioverativ Inc.
Gamida Cell

About Grand View Research

Cold Chain Market Share Worth Over $628.26 Billion by 2028

Cold Chain Market Growth & Trends

The global cold chain market size is estimated to reach USD 628.26 billion by 2028, according to a new study by Grand View Research, Inc., registering a CAGR of 14.8% from 2021 to 2028. Technological advancements in the packaging, processing, and storage of seafood products are expected to drive the market over the forecast period. Cold chain solutions have become an integral part of Supply Chain Management (SCM) for the transportation and storage of temperature-sensitive products. Increasing trade of perishable products is anticipated to drive product demand over the forecast period.

Companies operating in this market are increasingly adopting alternative energy solutions, such as wind and solar energy, to minimize the overall operating costs. Among cold chain solutions, the refrigeration system is used to maintain the quality of products and enhance their shelf life. However, refrigerants used in refrigeration systems pose a threat to the environment because of their high Global Warming Potential (GWP) and Ozone Depletion Potential (ODP). Stringent food safety regulations, such as the Food Safety Modernization Act that requires increased attention toward the construction of cold storage warehouses, are slated to benefit the market.

Adoption of environmental audit systems, such as Leadership in Energy and Environmental Design (LEED) or Building Research Establishment Environmental Assessment Method (BREEAM), can evaluate designs at an initial stage. Thus, the operational performance of completed buildings can be assessed through these audit systems. Temperature-controlled warehouses are highly energy-sensitive as they incorporate refrigeration and ventilation systems that require high power consumption. However, better designs can reduce power consumption and can help build net-zero energy warehouses.

Intelligent warehouse automation and control systems are one of the factors assisting buildings to achieve net-zero energy to become self-sustainable. Less energy consumption notably lowers operating expenditure, eventually contributing to the protection of ecology and climate. In terms of revenue, North America is anticipated to be the largest regional market by 2028. Mexico is expected to have exponential growth over the forecast period owing to the rising investments for the development of logistics infrastructure and increasing penetration of the Warehouse Management System (WMS).

In South America, Brazil is a major contributor to market growth. Implementation of dietary guidelines on the usage of fresh food products over processed food led by the Brazilian government is expected to boost the market in the country. These guidelines require the development of cold chains to meet the requirements for storage, transportation, and packaging of fresh food. Many service providers have invested in adding onboard tracking equipment to refrigeration units. This provides real-time location and temperature data to shippers and third-party logistics. It further helps them with increased visibility and opportunity to mitigate or prevent losses.

Request a free sample copy or view report summary: Cold Chain Market Report

Cold Chain Market Report Highlights

Due to a shift in focus from increasing productivity to providing better transport and storage facilities, the market has gained prominence in developing countries, such as China and India
Cold chain monitoring, smart packaging, sample lifecycle management, men and material tracking, and connected equipment are among IoT applications of key importance for the pharmaceuticals industry
Radio Frequency Identification (RFID)-enabled supply chain provides higher efficiency and has opened up new growth opportunities by offering product-level visibility
Globalization and rising number of pharmaceutical and food safety counterfeit incidents have compelled governments to tighten regulations pertaining to production and supply
The Government of India remains keen on supporting the development of the cold chain industry and is encouraging private participation by launching subsidy schemes and offering grants

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cold-chain-market

Cold Chain Market Segmentation

Grand View Research has segmented the global cold chain market on the basis of type, packaging, equipment, application, and region:

Cold Chain Type Outlook (Revenue, USD Million, 2017 - 2028)

Storage
- Warehouses
  - On-grid
  - Off-grid
- Reefer Containers
Transportation
- Road
- Sea
- Rail
- Air
Monitoring Components
- Hardware
  - Sensors
  - RFID Devices
  - Telematics
  - Networking Devices
- Software
  - On-premise
  - Cloud-based

Cold Chain Packaging Outlook (Revenue, USD Million, 2017 - 2028)

Product
- Crates
  - Dairy
  - Pharmaceuticals
  - Fishery
  - Horticulture
- Insulated Containers & Boxes
  - Payload Size
    - Large (32 to 66 liters)
    - Medium (21 to 29 liters)
    - Small (10 to 17 liters)
    - X-small (3 to 8 liters)
    - Petite (0.9 to 2.7 liters)
  - Type
    - Cold Chain Bags/Vaccine Bags
    - Corrugated Boxes
    - Others
  - Cold Packs
  - Labels
  - Temperature-controlled Pallet Shippers
- Materials
  - Insulating Materials
    - EPS
    - PUR
    - VIP
    - Cryogenic Tanks
    - Others (Insulating Pouches, Hard Cased Thermal Boxes, and Active Thermal Systems)
  - Refrigerants
    - Fluorocarbons
      - Inorganics
      - Ammonia
    - CO2
    - Hydrocarbons

Cold Chain Equipment Outlook (Revenue, USD Million, 2017 - 2028)

Storage Equipment
- On-grid
  - Walk-in Coolers
  - Walk-in Freezers
  - Ice-lined Refrigerators
  - Deep Freezers
- Off-grid
  - Solar Chillers
  - Milk Coolers
  - Solar-powered Cold Boxes
  - Others (Solar Refrigerators and Products related to Solar Panels)
- Transportation Equipment

Cold Chain Application Outlook (Revenue, USD Million, 2017 - 2028)

Fruits & Vegetables
Fruit Pulp & Concentrates
Dairy Products
- Milk
- Butter
- Cheese
- Ice cream
Fish, Meat, and Seafood
Processed Food
Pharmaceuticals
- Vaccines
- Blood Banking
Bakery & Confectionary
Others (Ready-to-Cook, Poultry)

Cold Chain Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
- Mexico
Asia Pacific
- China
- India
- Japan
- Singapore
- South Korea
Europe
- UK.
- Germany
- France
- Italy
- Spain
South America
- Brazil
Middle East
- UAE
- Saudi Arabia
- Israel
Africa
- South Africa
- Nigeria
- Egypt
- Kenya

List of Key Players of Cold Chain Market

Agro Merchant Group (U.S.)
Nordic Logistics and Warehousing, LLC (U.S.)
Preferred Freezer Services, LLC (U.S.)
Cold Chain Technologies, Inc. (U.S.)
Cryopack Industries, Inc. (U.S.)
Creopack (Canada)
Cold Box Express, Inc. (U.S.)

About Grand View Research

Stem Cell Market Value Expected To Increase at a CAGR of 8.8% from 2021 to 2028: Grand View Research Inc.

Stem Cells Market Growth & Trends

The global stem cells market size is expected to reach USD 18.4 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.8% during the forecast period. The market is driven by the rising number of stem cell banks, growing focus on increasing therapeutic potential of these, and extensive research for the development of regenerative medicines, among other factors.

Companies are receiving robust funding for the development of cellular therapies for cancer, which is anticipated to supplement the market growth. For instance, in February 2021, Notch Therapeutics, Inc. received funding of USD 85 million for developing induced pluripotent therapies for cancer. The investment will support the development of the company’s iPSC-derived T cell-based therapeutic candidates and expanding the application of their proprietary Engineered Thymic Niche (ETN) platform.

The increasing focus on regenerative medicines is further driving the market growth. The iPSCs are gaining popularity for the development of personalized cellular therapies and are creating new opportunities for regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can help in the treatment of placenta complications during pregnancy.

The researchers discovered a new way for creating induced trophoblast stem cells which can be used for making placenta cells. The discovery will facilitate in developing a model human placenta in vitro and enabling a pathway for future cell therapies. The administration of cell therapy demonstrated positive results in the treatment of COVID-19 patients, which is further contributing to the market growth. In January 2020, a group of researchers used stem cell treatment on patients in Beijing, China for checking its effectiveness against COVID-19.

The patients received a single infusion of mesenchymal stem cells (MSCs) which was found to be effective in developing an immune response. However, to date, there are no MSCs that are approved by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19 owing to insufficient data on their role in treating COVID-19.

Request a free sample copy or view report summary: Stem Cells Market Report

Stem Cells Market Report Highlights

ASCs segment accounted for the largest share of 85.7% in 2020 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
The iPSC segment is expected to witness a lucrative CAGR of 9.3% through 2021-2028 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company’s lead induced pluripotent stem cell (iPSC)-derived Cymerus
Regenerative medicine dominated with a market share of 89.1% in 2020 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of $300,000 from MTPConnect’s Industry Growth Centre Project Fund for the development of regenerative medicines in the country
Cell acquisition held the largest market share of 35.8% in 2020 and is expected to expand at the fastest CAGR through 2021-2028 owing to increasing research studies involving cell harvesting
Allogenic therapy dominated with a market share of 58.2% in 2020 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
The North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players.
Asia Pacific is expected to expand with the fastest CAGR of 9.0% through 2021 to 2028 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stem-cells-market

Stem Cells Market Segmentation

Grand View Research has segmented the global stem cells market based on product, application, technology, therapy, and region:

Stem Cells Product Outlook (Revenue, USD Million, 2017 - 2028)

Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Others
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic Like Stem Cells

Stem Cells Application Outlook (Revenue, USD Million, 2017 - 2028)

Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
Drug Discovery and Development

Stem Cells Technology Outlook (Revenue, USD Million, 2017 - 2028)

Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Stem Cells Therapy Outlook (Revenue, USD Million, 2017 - 2028)

Autologous
Allogenic

Stem Cells Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Spain
- Italy
Asia Pacific
- China
- Japan
- India
Latin America
- Brazil
- Mexico
Middle East & Africa
- South Africa
- Saudi Arabia

List of Key Players of Stem Cells Market

CELGENE CORPORATION
STEMCELL Technologies Inc.
Lineage Cell Therapeutics, Inc.
Osiris Therapeutics, Inc.
Human Longevity, Inc.
Cynata
Cytori Therapeutics Inc.
Advanced Cell Technology Inc.
Promethera Biosciences
Mesoblast Ltd

About Grand View Research

Demand Medical Imaging Market Increasing in Most Part of World 2028

Medical Imaging Market Growth & Trends

The global medical imaging market size is expected to reach USD 28.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. Increasing demand for advanced diagnostic systems in developing countries and growing trends of market player collaborations are some of the key factors driving the market.

Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players in the untapped market.

The integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the market at the global level.

The development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care.

Ongoing trials and studies to explore the potential of MRI technology for the early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.

Request a free sample copy or view report summary: Medical Imaging Market Report

Medical Imaging Market Report Highlights

By product, the ultrasound segment captured the largest share in 2020 and is expected to dominate throughout the forecast period. Computed tomography is expected to grow at the fastest rate during the forecast period due to rapid technological advancements, such as the development of hybrid imaging modalities and the integration of AI
Based on end use, the hospital's segment dominated the market in 2020 due to the blooming healthcare service industry in developing countries. The ambulatory imaging centers segment is anticipated to witness the fastest growth during the forecast period
North America captured the largest market share in 2020 due to the presence of a large number of industry players and the high frequency of new product launches

Access Press Release@ https://www.grandviewresearch.com/press-release/medical-imaging-systems

Medical Imaging Market Segmentation

Grand View Research has segmented the global diagnostic imaging market on the basis of product, end use, and region:

Medical Imaging Product Outlook (Revenue, USD Million, 2016 - 2028)

X-ray
- By Modality
  - Radiography
  - Fluoroscopy
  - Computed Radiography
- By Mobility
  - Stationary
  - Mobile
- By Product
  - Digital
  - Analog
- By Application
  - General radiology
  - Dental
  - Breasts
  - Cardiology
  - Others
- Ultrasound
  - By Product
    - 2D
    - 3D/4D
    - Doppler Ultrasound Devices
  - By Portability
    - Handheld
    - Cart/Trolley Based
  - By Application
    - Ob/Gyn
    - Cardiovascular
    - Musculoskeletal
    - Others
  - Computed Tomography
    - By Technology
      - High-end slice
      - Mid-end slice
      - Low-end slice
      - Cone beam
    - By Application
      - Oncology
      - Neurology
      - Cardiology
      - Vascular
      - Musculoskeletal
      - Others
    - Magnetic Resonance Imaging
      - By Architecture
        Closed System
        Open System
      - By Field Strength
        Low Field Strength
        Mid Field Strength
        High Field Strength
      - By Application
        Brain and neurological
        Spine and musculoskeletal
        Vascular
        Abdomen
        Cardiac
        Breast
        Other
      - Nuclear Imaging
        By Product
        SPECT
        Hybrid SPECT
        Standalone SPECT
        Hybrid PET
        Planar Scintigraphy
        By Application
        Oncology
        Cardiology
        Neurology
        General Imaging

Medical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals
Diagnostic Imaging Centers
Ambulatory Imaging Centers
Others

Medical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Turkey
- Poland
Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Malaysia
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Iran

List of Key Players of Medical Imaging Market

GE Healthcare
Koninklijke Philips N.V.
Siemens Healthineers
CANON MEDICAL SYSTEMS CORPORATION
Bruker
Mediso Ltd.
MILabs B.V.
MR Solutions
TriFoil Imaging
PerkinElmer Inc.
FUJIFILM VisualSonics Inc.
Cubresa Inc.

About Grand View Research

Abrasive Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

Abrasive Market Growth & Trends

The global abrasive market size is expected to reach USD 47.82 billion by 2028, expanding at a CAGR of 4.2% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to be driven by the rising growth in the metal fabrication industry on account of demand from the end-use sectors, such as automotive, aerospace, agriculture, and medical. Abrasives are tools used for shaping and providing a smooth finish to the surface of the product.

Based on product, the market has been segmented into coated, bonded, and others. The coated segment is anticipated to register the fastest growth rate over the forecast period on account of the increasing application of coated materials in metalworking, where products, such as sandpaper, are used for deburring. China held the largest share of the global market in 2020. The country leads in terms of production as well to cater to domestic demand, as it is also a huge manufacturing hub.

According to the USGS statistics, China was the largest producer of fused aluminum oxide and silicon carbide abrasives in 2019. Rising production in China has compelled other players in the value chain to expand their manufacturing capacities. For instance, in August 2020, Ahlstrom-Munksjö announced to make further investments in its Binzhou plant for producing abrasive backing paper. This investment aims at strengthening the company’s position as a leading producer for abrasive backings across the globe.

Despite the positive market outlook for the future, the market growth plummeted in 2020 on account of the Covid-19 pandemic. Several companies witnessed losses in 2020 as the manufacturing operations were suspended, which impacted both product manufacturing and consumption. For example, Grindwell Norton Ltd.’s abrasives division reported a drop in sales due to a decline in industrial activity and lockdown in the first quarter of 2020.

Request a free sample copy or view report summary: Abrasive Market Report

Abrasive Market Report Highlights

The bonded products segment held the largest revenue share of over 43% in 2020 owing to increasing demand for these products from numerous industries including steel, automotive, cutting tools, food processing, and general engineering, among others
The automotive & transportation application dominated the market with a share of more than 35% in 2020 and will retain the leading position throughout the forecast years
The growth of this application segment can be attributed to the increasing production of Electric Vehicles (EVs) and the rising number of their charging stations
Metal fabrication is anticipated to register the fastest CAGR during the forecast period. Metal fabricators look for high-performance abrasive discs and finishing materials to reduce the downtime of fabrication operations
Asia Pacific is anticipated to register the fastest growth rate of 4.7% over the forecast period on account of rapid growth in the manufacturing sector in the developing economies, such as India, China, and South Korea

Access Press Release@ https://www.grandviewresearch.com/press-release/global-abrasives-market

Abrasive Market Segmentation

Grand View Research has segmented the global abrasive market on the basis of product, application, and region:

Abrasive Product Outlook (Revenue, USD Million, 2017 - 2028)

Bonded
Coated
Others

Abrasive Application Outlook (Revenue, USD Million, 2017 - 2028)

Automotive & Transportation
Heavy Machinery
Metal Fabrication
Electrical & Electronics Equipment
Others

Abrasive Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
- Mexico
Europe
- Germany
- UK.
- France
- Italy
- Russia
Asia Pacific
- China
- India
- Japan
- Australia
Central & South America
- Brazil
Middle East & Africa

List of Key Players of Abrasive Market

3M
Asahi Diamond Industrial Co., Ltd.
Bosch Ltd.
CUMI
Henkel AG & Co, KGaA
Saint-Gobain

About Grand View Research

LED Lighting Market to Reach Around USD 135.58 Billion by 2028: Grand View Research Inc.

LED Lighting Market Growth & Trends

The global LED lighting market size is expected to reach USD 135.58 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 12.5% over the forecast period. LED lighting offers benefits, such as improved energy efficiency, low heat emission, cost-saving, directional controlled lighting, longer service life, and nanosecond switching, which have been instrumental in driving the market growth.

In addition, the flexibility of using LED lighting for complex, compact shape, and aesthetically pleasing design fixtures has led to higher adoption rates, specifically across residential and commercial spaces. LED manufacturers are incorporating features, such as occupancy sensor, daylighting (bright white-blue light), dim-ability, and timer, to attain smart lighting capabilities at affordable prices.

Moreover, favorable government policies, rebates, and retrofit programs for commercial, industrial, and residential sectors to encourage the adoption of LED lighting are driving the market growth over the forecast period. Flicker-free LED lighting was introduced to reduce power consumption, facilitate long service life, and reduce the consumption of inefficient, high-wattage light sources, such as incandescent, HID, and CFL.

The market has been transforming radically in line with the continued advancements in LED lighting and semiconductor technology as well as the growing demand for sustainable and energy-efficient solutions. The advent of connected and controlled lighting technology has boosted the demand for lamps and fixtures. For instance, the Hue Lighting by Philips is a smart home lighting system that provides an entire range of lights that can be controlled using the Hue app on smartphones.

The growing preference for smart and Wi-Fi-enabled light bulbs is expected to emerge as one of the prominent factors driving the market growth over the forecast period. The Covid-19 pandemic disrupted lifestyle and business operations worldwide. Due to the delayed construction projects, owing to a temporary shutdown, the LED lights’ purchase order, delivery timeline, and payments were delayed, resulting in low revenue generation for the manufacturers.

Moreover, the companies relying on raw material suppliers from China faced delays, which hampered the production of new LED lamps and luminaires. Hence, the global market witnessed a decline in the overall revenue in the year 2020. The market was expected to recover in 2021 with reduced Covid-19 cases; however, the pandemic's second wave for an uncertain period is likely to affect the year-on-year growth rate. However, the improved knowledge about Covid-19 and continued business functions with preventive measures seem to be favorable for increasing the product demand over the forecast period.

Request a free sample copy or view report summary: LED Lighting Market Report

LED Lighting Market Report Highlights

The rising demand for different product types for enhancing the aesthetics in luxury hotels, office spaces, as well as residential spaces is contributing to the market growth
The lamps segment is anticipated to register the highest CAGR over the forecast period. The residential and commercial sectors primarily drive the demand for A-type, T-type, R-type, and B- & C-shaped wall and table lamps owing to their visibly pleasing aesthetics and varied illumination capability to enhance indoor and outdoor spaces
Asia Pacific is expected to lead the global, in terms of revenue share as well as growth rate, over the forecast period
The growth of APAC market is credited to the presence of large-scale manufacturers hotels, malls, and other commercial spaces in countries, such as China, India, Indonesia, Japan, and Vietnam
Most of the major players offer an array of products for residential, commercial, and industrial applications
Vendors in this market have been relying on an inorganic growth strategy to capture higher market shares
For instance, Signify Holdings acquired GE Lighting and Philips to extend its product portfolio and expand its geographical footprint

Access Press Release@ https://www.grandviewresearch.com/press-release/global-led-lighting-market

LED Lighting Market Segmentation

Grand View Research has segmented the global LED lighting market on the basis of product, application, end-use, and region:

LED Lighting Product Outlook (Revenue, USD Billion, 2016 - 2028)

Lamps
- A-Lamps
- T-Lamps
- Others
Luminaires
- Streetlights
- Downlights
- Troffers
- Others

LED Lighting Application Outlook (Revenue, USD Billion, 2016 - 2028)

Indoor
Outdoor

LED Lighting End-use Outlook (Revenue, USD Billion, 2016 - 2028)

Commercial
Residential
Industrial
Others

LED Lighting Regional Outlook (Revenue, USD Billion 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
Asia Pacific
- China
- India
- Japan
Latin America
- Brazil
- Mexico
Middle East & Africa

List of Key Players of LED Lighting Market

Acuity Brands Lighting, Inc.
Cree Lighting (Ideal Industries, Inc.)
Dialight
Digital Lumens, Inc.
Hubbell
LSI Industries, Inc.
Panasonic Corp.
Siteco GmbH
Signify Holding
Zumtobel Group

About Grand View Research

Lactic Acid Market Expected To Propel Industry Growth By 2028: Grand View Research Inc.

Lactic Acid Market Growth & Trends

The global lactic acid market size is expected to reach USD 5.02 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2021 to 2028. The market growth can be attributed to the increasing demand for lactic acid in various end-use industries, including industrial, food and beverages, and pharmaceuticals, especially in emerging economies such as India, China, and Indonesia. Additionally, demand for this product as a feedstock in the production of polylactic acid (PLA) is anticipated to drive the market globally.

Various raw materials used for the production of lactic acid include carbohydrates such as corn, sugarcane, sugar beet, and tapioca. A large share of this product produced globally is obtained through the fermentation process owing to its lower production costs as well as rising consumer awareness regarding sustainable and environmentally friendly products. The production process is commercially mature with a significant number of manufacturers, including Corbion, NatureWorks LLC, Galactic, and Henan Jindan Lactic Acid Technology Co., Ltd., using it.

The raw materials used for the commercial synthesis of this product include maltose or starch, lactose, sucrose, and glucose. These raw materials are derived from various feedstocks, such as barley malt, whey, molasses, and beet sugar, which are used to produce lactic acid via microbial fermentation. The cost of raw material is a key factor to be considered in the fermentation process for the commercial production of this product. They may specifically cater to application areas such as industrial, food and beverage, pharmaceuticals, personal care, chemicals, and agrochemicals.

Polylactic acid is predominantly used to manufacture microwaveable containers, including disposable cutlery and food containers. Multiple beneficial properties such as improved aesthetic appeal and resistance to grease and oil are positively influencing the demand for polylactic acid in the formulation of food packaging products across the globe, further triggering the lactic acid demand.

Request a free sample copy or view report summary: Lactic Acid Market Report

Lactic Acid Market Report Highlights

In 2020, sugarcane emerged as the dominant raw material segment with a revenue share of over 39.0% owing to its abundant availability in nature, low cost, and environmental friendliness
Corn emerged as the second-largest raw material segment in 2020 and is projected to witness considerable growth over the forecast period owing to the rising awareness regarding sustainable products in the major application industries
PLA emerged as the dominant application segment in 2020 in terms of both volume and revenue owing to the rising usage in the manufacturing of biodegradable and biocompatible products
In 2020, North America emerged as the largest regional market due to the presence of major personal care and cosmetic industries in this region, especially in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-lactic-acid-and-poly-lactic-acid-market

Lactic Acid Market Segmentation

Grand View Research has segmented the global lactic acid market on the basis of raw material, application, and region:

Lactic Acid Raw Material Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

Corn
Sugarcane
Cassava
Other Crops

Lactic Acid Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

Industrial
Food & Beverages
Pharmaceuticals
Personal Care
Polylactic Acid (PLA)
Others

Lactic Acid Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
- Mexico
Europe
- Germany
- France
- UK.
- Italy
- Netherlands
Asia Pacific
- China
- Japan
- India
- Indonesia
- Malaysia
- Philippines
Central & South America (CSA)
- Brazil
Middle East & Africa (MEA)

List of Key Players of Lactic Acid Market

BASF SE
Galactic
Musashino Chemical (China) Co., Ltd.
Futerro
Corbion
Dow
TEIJIN LIMITED

About Grand View Research

Synthetic Leather Market Set to Surge Significantly During 2021-2028: Grand View Research Inc.

Synthetic Leather Market Growth & Trends

The global synthetic leather market size is anticipated to reach USD 57.0 billion by 2028, according to a new report by Grand View Research, Inc., growing at a CAGR of 7.8% from 2021 to 2028. Increasing product application scope in footwear has been a major factor driving the market growth. In addition, growing importance and awareness about animal rights and stringent laws regarding the usage of real leather are propelling the demand for its synthetic counterpart. Synthetic leather materials offer superior properties, such as high gloss finish, durability, strength, and UV resistance, and easy maintenance. Moreover, products made from faux leather are cheaper and thus, continue to attract consumers, especially from middle- and high-income level groups.

However, in countries, such as Japan, the product is facing competition from Fumikodata, which is a replica of real leather and is a cruelty-free material. Polyurethane (PU) was the largest product category in 2020 and is expected to register the fastest CAGR over the forecast period. Polyvinyl Chloride (PVC) is anticipated to witness sluggish growth on account of its properties, such as sticky finish and low durability. The footwear application segment is expected to observe considerable growth over the upcoming years. Cheaper costs and fluctuating climatic conditions in several regions create the need for different types of footwear.

Rising disposable income levels in emerging regions are also fueling the product demand in the footwear segment. Moreover, the trend of incorporating athletic shoes in daily lifestyle is further augmenting the product demand. Consumer spending in the U.S. and some European countries has slowed down slightly owing to the global recession. However, the footwear industry has witnessed significant growth in the emerging markets due to high product demand from countries, such as China, India, South Korea, Vietnam, Thailand, and other South Asian countries.

Request a free sample copy or view report summary: Synthetic Leather Market Report

Synthetic Leather Market Report Highlights

The global market is expected to witness significant growth over the forecast period owing to rising product demand in the footwear and automotive applications
PU leather emerged as the largest product segment in 2020 and is estimated to generate revenue over USD 35.6 billion by 2028
Asia Pacific is projected to be the fastest-growing as well as the largest regional market over the estimated period
The market growth in APAC can be credited to the rapid economic growth across countries, such as India, China, Japan, and Korea
In addition, the rapid development of the construction and automotive manufacturing industries in APAC is fueling the product demand further
Countries, such as South Korea, Taiwan, China, and India, are emerging as leading producers in the global market as a result of the availability of relatively cheaper raw materials

Access Press Release@ https://www.grandviewresearch.com/press-release/global-synthetic-leather-market

Synthetic Leather Market Segmentation

Grand View Research has segmented the global synthetic leather market on the basis of product, application, and region:

Synthetic Leather Product Outlook (Volume, Million Meter; Revenue, USD Million, 2016 - 2028)

PU
PVC
Bio-based

Synthetic Leather Application Outlook (Volume, Million Meter; Revenue, USD Million, 2016 - 2028)

Furnishing
Automotive
Footwear
Bags & Wallets
Clothing
Others

Synthetic Leather Regional Outlook (Volume, Million Meter; Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
- Mexico
Europe
- Germany
- Italy
- France
- UK.
Asia Pacific
- China
- Japan
- India
- South Korea
Central & South America
- Brazil
Middle East & Africa

List of Key Players of Synthetic Leather Market

Kuraray Co., Ltd.
R. Polycoats Pvt. Ltd.
Nan Ya Plastics Corp.
Teijin Ltd.
Alfatex Italia SRL

About Grand View Research

Cardiac Rhythm Management Devices Market Revenue is expected to Reach USD 29.9 Billion by 2028: Grand View Research Inc.

Cardiac Rhythm Management Devices Market Growth & Trends

The global cardiac rhythm management devices market size is anticipated to reach USD 29.9 billion by 2028, according to a new report by Grand View Research. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. The market has shown constant growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the CDC, as of September 2020, approximately 655,000 Americans die suffering from heart disease every year.

The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic. Major players in the market, such as Medtronic, Abbott, and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020.

Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. Increase in R&D expenditure and new product launches by leading firms is driving the market. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, to expand its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Some of the major market players account for a significant share of the market owing to their extensive product offerings.

Request a free sample copy or view report summary: Cardiac Rhythm Management Devices Market Report

Cardiac Rhythm Management Devices Market Report Highlights

The defibrillator segment held the largest revenue share in 2020 owing to high acceptance of the device, globally
The ICD segment dominated the defibrillators segment in 2020 and accounted for more than 60.0% of the revenue share, owing to its better patient outcome
In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share in 2020 owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat
In 2020, North America held the dominant revenue share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices
Asia Pacific is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cardiac-rhythm-management-crm-devices-market

Cardiac Rhythm Management Devices Market Segmentation

Grand View Research has segmented the global cardiac rhythm management devices market on the basis of the product and region:

CRM Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

Pacemakers
- Implantable
- External
Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
  - S-ICD
  - T-ICD
- External Defibrillator
  - Manual External Defibrillator
  - Automatic External Defibrillator
  - Wearable Cardioverter Defibrillator
- Cardiac Resynchronization Therapy (CRT)
  - CRT-Defibrillator
  - CRT-Pacemakers

CRM DevicesRegional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Australia
Latin America
- Brazil
- Mexico
Middle East & Africa
- South Africa
- Saudi Arabia

List of Key Players of Cardiac Rhythm Management (CRM) Devices Market

Physio-Control, Inc. (Stryker)
Schiller
Medtronic
Abbott
Boston Scientific Corporation
Koninklijke Philips N.V.
Zoll Medical Corporation
BIOTRONIK
Progetti Srl

About Grand View Research

Market Research Size

Tuesday, 27 April 2021

Pharmacy Automation Devices Market is Anticipated to Upgrade $9.5 Billion Revenue By 2028: Grand View Research Inc.

Pharmacy Automation Devices Market Growth & Trends

Pharmacy Automation Devices Market Report Highlights

Pharmacy Automation Devices Market Segmentation

Monday, 26 April 2021

Hemoglobinopathies Market Valuation to Reach $15.7 Billion by the end of 2028

Hemoglobinopathies Market Growth & Trends

Hemoglobinopathies Market Report Highlights

Hemoglobinopathies Market Segmentation

Cold Chain Market Share Worth Over $628.26 Billion by 2028

Cold Chain Market Growth & Trends

Cold Chain Market Report Highlights

Cold Chain Market Segmentation

Stem Cell Market Value Expected To Increase at a CAGR of 8.8% from 2021 to 2028: Grand View Research Inc.

Stem Cells Market Growth & Trends

Stem Cells Market Report Highlights

Stem Cells Market Segmentation

Demand Medical Imaging Market Increasing in Most Part of World 2028

Abrasive Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

LED Lighting Market to Reach Around USD 135.58 Billion by 2028: Grand View Research Inc.

Lactic Acid Market Expected To Propel Industry Growth By 2028: Grand View Research Inc.

Synthetic Leather Market Set to Surge Significantly During 2021-2028: Grand View Research Inc.

Cardiac Rhythm Management Devices Market Revenue is expected to Reach USD 29.9 Billion by 2028: Grand View Research Inc.

Patient Monitoring Accessories Market Poised to Expand at a Robust Pace Over 2033: Grand View Research Inc.

Search This Blog